The most common reason for a negative Pap test with a positive HPV result is that the patient has an HPV infection, but the infection is not causing any cellular abnormalities.
The response to certain drug regimens in patients with non-small cell carcinoma (NSCLC) with adenocarcinoma is different from squamous cell carcinoma patient response.
Candida is always present in and on the body in small amounts; however, Candida can multiply when an imbalance occurs, such as when normal acidity of the vagina is altered or when hormonal balance changes.
The number of HPV-related oropharyngeal carcinomas is on the rise according to the Annual Report to the Nation on the Status of Cancer, 1975-2009; however, we still don’t have an accepted screening protocol in place to address the situation.
In our world of rapidly evolving technology, does molecular testing for infectious disease offer value? If there is a current practice or test that detects disease and helps administer good care to patients, is there reason to readily adopt a new approach?
Recommendations for setting the appropriate margins when excising melanoma in situ (MIS) lesions are being revisited.
Accurate interpretation of bone marrow specimens is highly dependent on two factors: the quality of the sample obtained during the procedure and the quality of specimen processing, in particular the preparation of the bone marrow aspirate smears.
Recent studies reveal that tumor HPV status is an independent prognostic factor for overall survival and progression-free survival among patients with oropharyngeal squamous cell carcinomas.
When indeterminate thyroid results are reported, there are options available for clinicians and their patients to obtain additional diagnostic information, which may help in deciding whether or not to have surgery.
Incyte Diagnostics Adopts ToGA Guidelines: Gastric and Esophageal Adenocarcinoma Testing for HER2 Status - IHC vs. FISH
At Incyte Diagnostics, we have adopted the ToGA guidelines. We will test a patient’s first biopsy with IHC for HER2 with reflex to ISH (FISH or CISH) for equivocal HER2 by IHC results.